Navigation Links
Bend Research Offers Broad Access to Drug-Delivery Solutions
Date:10/20/2008

BEND, Ore., Oct. 20 /PRNewswire/ -- Bend Research Inc. announced today that it will independently offer unique drug-delivery expertise and technologies to outside firms in the pharmaceutical and biotechnology industries.

Bend Research will continue its 23-year collaboration with Pfizer but will also be free to work with outside firms using proprietary technologies developed jointly by the two firms.

These technologies include the spray-dried dispersion (SDD) technology (which increases the oral bioavailability of low-solubility compounds), controlled-release, multiparticulate, and pulmonary delivery platforms.

Bend Research CEO Rod Ray commented: "Our work with Pfizer has helped us tremendously to grow and develop our capabilities over the past two decades. In return, we have helped Pfizer advance a significant number of their compounds. Today, we're pleased to have the opportunity to collaborate with additional clients to enable the delivery of new medicines."

Kelvin Cooper, Senior Vice President of Worldwide Pharmaceutical Sciences for Pfizer Global Research and Development, agreed: "Our collaboration with Bend Research has proved to be valuable and we look forward to continued work with Bend Research. Through this agreement, we hope the technologies we've developed together will help speed the introduction of new medicines to patients throughout the world."

Under terms of the agreement with Pfizer, Bend Research will have the ability to employ expertise and processes developed with Pfizer to benefit other drug developers. These include optimized drug discovery, dosage form development, engineering capabilities, and manufacture of supplies for clinical trials under Good Manufacturing Practice (GMP) conditions.

Bend Research will continue to work exclusively with Pfizer on certain specific technology platforms. This commitment reaffirms the strong relationship between the two companies while providing enabling technologies for improved world health

About Bend Research Inc.

Bend Research Inc. is an interdisciplinary technology-, science-, and engineering-driven company that discovers, advances, develops, and commercializes pharmaceutical and healthcare products through the application of technology platforms. This capability is driven by scientific and engineering excellence. The company has three facilities based in Bend, Oregon.


'/>"/>
SOURCE Bend Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
2. The Wellness Community Announces National Cancer Survivorship Research & Training Institute in Philadelphia
3. Research May Help Predict Preeclampsia
4. Georgetown University Med Center reproductive health researchers tackle public health concerns
5. Monash wins $32m for health and medical research
6. New research shows that the smell of smoke does not trigger relapse in quitters
7. Stem-cell sentry sounds the alarm to maintain balance between cancer and aging, U-M researchers find
8. American Cancer Society awards research grants to 116 investigators at 75 institutions nationwide
9. Steroids aid recovery from pneumonia, UT Southwestern researchers say
10. Carnegie Mellon International Autism Symposium to Feature Groundbreaking Research, Oct. 17-18
11. MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: